Trial intelligence / Profile preview

Phase III trial of Shufeng Zhitong Capsules for migraine prevention

CTR20254404Phase 3Active

Sponsor
Bossly Pharmaceutical
Start
Mar 2026
Countries
1
01

Overview

A Phase 3 trial of Shufeng Zhitong Capsules in migraine, sponsored by Bossly Pharmaceutical. Started Mar 2026; status: active.

02

Drugs

Shufeng Zhitong Capsules
03

Conditions

migraine

Beyond the preview

Go deeper on CTR20254404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20254404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call